# STOCKHOLM 1.0

#=GF AC   RF02207
#=GF ID   WT1-AS_5
#=GF DE   WT1 antisense RNA conserved region 5
#=GF AU   Eberhardt R; 0000-0001-6152-1369
#=GF SE   Predicted; CMfinder
#=GF SS   Predicted; CMfinder
#=GF GA   80.00
#=GF TC   89.00
#=GF NC   47.50
#=GF TP   Gene; lncRNA;
#=GF BM   cmbuild -F CM SEED
#=GF CB   cmcalibrate --mpi CM
#=GF SM   cmsearch --cpu 4 --verbose --nohmmonly -T 21.44 -Z 549862.597050 CM SEQDB
#=GF DR   SO; 0001463; lincRNA;
#=GF RN   [1]
#=GF RM   2173145
#=GF RT   Tissue, developmental, and tumor-specific expression of divergent
#=GF RT   transcripts in Wilms tumor.
#=GF RA   Huang A, Campbell CE, Bonetta L, McAndrews-Hill MS, Chilton-MacNeill S,
#=GF RA   Coppes MJ, Law DJ, Feinberg AP, Yeger H, Williams BR
#=GF RL   Science. 1990;250:991-994.
#=GF RN   [2]
#=GF RM   8406502
#=GF RT   Sequence of the WT1 upstream region including the Wit-1 gene.
#=GF RA   Gessler M, Bruns GA
#=GF RL   Genomics. 1993;17:499-501.
#=GF RN   [3]
#=GF RM   17210670
#=GF RT   A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and
#=GF RT   exhibits sequential epigenetic defects during Wilms' tumourigenesis.
#=GF RA   Hancock AL, Brown KW, Moorwood K, Moon H, Holmgren C, Mardikar SH,
#=GF RA   Dallosso AR, Klenova E, Loukinov D, Ohlsson R, Lobanenkov VV, Malik K
#=GF RL   Hum Mol Genet. 2007;16:343-354.
#=GF WK   WT1-AS
#=GF SQ   4


AL049692.13/51819-51741 GGCACUUUUAGCGGGGGGAGAGGAGGUUAUCUGAAGGGA----GGCUGGCUUGAAUGUGAGUCGUUGUGUUUGUGAAACCCAG
L25110.1/3560-3638      GGCACUUUUAGCGGGGGGAGAGGAGGUUAUCUGAAGGGA----GGCUGGCUUGAAUGUGAGUCUUUGUGUUUGUGAAACCCAG
X77549.1/328-250        GGCACUUUUAGCGGGGGGAGAGGAGGUUAUCUGAAGGGA----GGCUGGCUUGAAUGUGAGUCGUUGUGUUUGUGAAACCCAG
AANU01216576.1/178-102  GGCCCUUUUAGCGGGGGGAGAGGAGGUUAUCUGAAGGGAGGGAGGCAGGCUUGAAUGUGAGUC------UUUGUGAAACCCAG
#=GC SS_cons            :::::::::::::::::::::::::::::::::::::::....::::::::::::::::::::::::::::::::::::::::
#=GC RF                 GGCaCUUUUAGCGGGGGGAGAGGAGGUUAUCUGAAGGGA....GGCuGGCUUGAAUGUGAGUCgUUGUGUUUGUGAAACCCAG
//
